Aug 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 2.09B | $ 1.00B | $ 1.73B | $ 1.55B | $ 1.49B |
Total Assets | $ 27.09B | $ 26.91B | $ 25.68B | $ 25.16B | $ 26.47B |
Total Debt | $ 7.27B | $ 7.38B | $ 7.30B | $ 6.84B | $ 6.94B |
Net Debt | $ 5.18B | $ 6.38B | $ 5.58B | $ 5.29B | $ 5.44B |
Total Liabilities | $ 19.16B | $ 18.49B | $ 18.60B | $ 18.56B | $ 19.28B |
Stockholders Equity | $ 7.93B | $ 8.42B | $ 7.08B | $ 6.60B | $ 7.19B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |